137 related articles for article (PubMed ID: 32596526)
1. Severe CIDP-MGUS responsive to Rituximab.
Posa A; Emmer A; Kornhuber M
Heliyon; 2020 Jun; 6(6):e04230. PubMed ID: 32596526
[TBL] [Abstract][Full Text] [Related]
2. Chronic inflammatory demyelinating polyradiculoneuropathy: comparison of patients with and without an associated monoclonal gammopathy.
Bromberg MB; Feldman EL; Albers JW
Neurology; 1992 Jun; 42(6):1157-63. PubMed ID: 1603342
[TBL] [Abstract][Full Text] [Related]
3. Presentation and initial clinical course in patients with chronic inflammatory demyelinating polyradiculoneuropathy: comparison of patients without and with monoclonal gammopathy.
Simmons Z; Albers JW; Bromberg MB; Feldman EL
Neurology; 1993 Nov; 43(11):2202-9. PubMed ID: 8232929
[TBL] [Abstract][Full Text] [Related]
4. Chronic inflammatory demyelinating polyneuropathy: clinical features and response to treatment in 67 consecutive patients with and without a monoclonal gammopathy.
Gorson KC; Allam G; Ropper AH
Neurology; 1997 Feb; 48(2):321-8. PubMed ID: 9040714
[TBL] [Abstract][Full Text] [Related]
5. Long-term follow-up of patients with chronic inflammatory demyelinating polyradiculoneuropathy, without and with monoclonal gammopathy.
Simmons Z; Albers JW; Bromberg MB; Feldman EL
Brain; 1995 Apr; 118 ( Pt 2)():359-68. PubMed ID: 7735878
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic criteria for demyelinating polyneuropathy associated with monoclonal gammopathy.
Notermans NC; Franssen H; Eurelings M; Van der Graaf Y; Wokke JH
Muscle Nerve; 2000 Jan; 23(1):73-9. PubMed ID: 10590408
[TBL] [Abstract][Full Text] [Related]
7. Treatment of immune-mediated, dysimmune neuropathies.
Finsterer J
Acta Neurol Scand; 2005 Aug; 112(2):115-25. PubMed ID: 16008538
[TBL] [Abstract][Full Text] [Related]
8. Fibrillary glomerulonephritis combined with chronic inflammatory demyelinating polyneuropathy.
Sung WK; Jeong JU; Bang KT; Shin JH; Yoo JH; Kim NM; Park JH; Kim JH
Kidney Res Clin Pract; 2015 Jun; 34(2):117-9. PubMed ID: 26484033
[TBL] [Abstract][Full Text] [Related]
9. Comparison of monoclonal gammopathy of undetermined significance-associated neuropathy and chronic inflammatory demyelinating polyneuropathy patients.
Alkhawajah NM; Dunnigan SK; Bril V
J Neurol; 2014 Aug; 261(8):1485-91. PubMed ID: 24801490
[TBL] [Abstract][Full Text] [Related]
10. Different types of chronic inflammatory demyelinating polyneuropathy have a different clinical course and response to treatment.
Jann S; Beretta S; Bramerio MA
Muscle Nerve; 2005 Sep; 32(3):351-6. PubMed ID: 16003765
[TBL] [Abstract][Full Text] [Related]
11. [Polyneuropathy associated with monoclonal gammopathy of undetermined significance].
Moth Henriksen M; Kolmos EB; Abildgaard N; Schrøder HD; Sindrup S
Ugeskr Laeger; 2012 Oct; 174(43):2630-4. PubMed ID: 23095652
[TBL] [Abstract][Full Text] [Related]
12. Proposed revised electrophysiological criteria for chronic inflammatory demyelinating polyradiculoneuropathy.
Nicolas G; Maisonobe T; Le Forestier N; Léger JM; Bouche P
Muscle Nerve; 2002 Jan; 25(1):26-30. PubMed ID: 11754181
[TBL] [Abstract][Full Text] [Related]
13. Sensitivity and specificity of electrodiagnostic criteria for CIDP using ROC curves: comparison to patients with diabetic and MGUS associated neuropathies.
Wilson J; Chawla J; Fisher M
J Neurol Sci; 2005 Apr; 231(1-2):19-28. PubMed ID: 15792816
[TBL] [Abstract][Full Text] [Related]
14. Clinical features, evaluation, and treatment of patients with polyneuropathy associated with monoclonal gammopathy of undetermined significance (MGUS).
Gorson KC
J Clin Apher; 1999; 14(3):149-53. PubMed ID: 10540371
[TBL] [Abstract][Full Text] [Related]
15. Multiple Myeloma Associated Chronic Inflammatory Demyelinating Polyradiculoneuropathy: The Importance of Continued Surveillance.
Fasanya AA; Loncharich MF; Gandhi V; Rana S; Balaan M
Cureus; 2016 Nov; 8(11):e899. PubMed ID: 28070468
[TBL] [Abstract][Full Text] [Related]
16. [A case of chronic inflammatory demyelinating polyradiculoneuropathy concomitant with acquired von Willebrand syndrome].
Ueda M; Kawamura N; Tateishi T; Shigeto H; Ohyagi Y; Kira J
Rinsho Shinkeigaku; 2011 May; 51(5):334-7. PubMed ID: 21706830
[TBL] [Abstract][Full Text] [Related]
17. [A case of severe chronic inflammatory demyelinating polyradiculoneuropathy with monoclonal gammopathy of undetermined significance with alternating immunoglobulin class to IgM from IgA].
Hayashi S; Nagamine S; Makioka K; Kusunoki S; Okamoto K
Rinsho Shinkeigaku; 2016 Sep; 56(9):593-9. PubMed ID: 27580763
[TBL] [Abstract][Full Text] [Related]
18. Are neurological complications of monoclonal gammopathy of undetermined significance underestimated?
Steiner N; Schwärzler A; Göbel G; Löscher W; Wanschitz J; Gunsilius E
Oncotarget; 2017 Jan; 8(3):5081-5091. PubMed ID: 27974705
[TBL] [Abstract][Full Text] [Related]
19. Does the chronic inflammatory demyelinating polyradiculoneuropathy due to secondary cause differ from primary?
Wadwekar V; Kalita J; Misra UK
Neurol India; 2011; 59(5):664-8. PubMed ID: 22019647
[TBL] [Abstract][Full Text] [Related]
20. Recurrent Isolated Sixth Nerve Palsy in Relapsing-Remitting Chronic Inflammatory Demyelinating Polyneuropathy.
Al-Bustani N; Weiss MD
J Clin Neuromuscul Dis; 2015 Sep; 17(1):18-21. PubMed ID: 26301375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
